Structured evidence table for Omega-3 Supplementation Triglycerides Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Omega-3 Supplementation Triglycerides Meta-Analysis | Neutral findings likely reflect moderate-dose combined EPA + DHA use, limited subgroup reporting on metabolic comorbidities (e.g., diabetes, hypertriglyceridemia) or concomitant therapies (e.g., statins), and high background guideline-directed medical therapy reducing residual risk. | 1 | Shayan SK (2026) | Meta Analysis of DHA and EPA Supplementation on Cardiovascular Outcomes and Atrial Fibrillation Risk. |
| Omega-3 Supplementation Triglycerides Meta-Analysis | Although omega-3 fatty acids exert anti-inflammatory, antithrombotic, and lipid-modulating effects, this analysis indicates no broad benefit in reducing MACE or AF risk with combined moderate-dose EPA + DHA in heterogeneous post-event populations. | 1 | Shayan SK (2026) | Meta Analysis of DHA and EPA Supplementation on Cardiovascular Outcomes and Atrial Fibrillation Risk. |
| Omega-3 Supplementation Triglycerides Meta-Analysis | Recent evidence highlights more MACE reductions with high-dose purified EPA monotherapy in high-metabolic-risk subgroups, balanced against dose-dependent AF increases at high doses (> 1.5 g/day). | 1 | Shayan SK (2026) | Meta Analysis of DHA and EPA Supplementation on Cardiovascular Outcomes and Atrial Fibrillation Risk. |
| Omega-3 Supplementation Triglycerides Meta-Analysis | Cardiovascular diseases (CVD) remain to impose a main global burden of morbidity and mortality despite advances in anticipation and treatment. | 1 | Shayan SK (2026) | Meta Analysis of DHA and EPA Supplementation on Cardiovascular Outcomes and Atrial Fibrillation Risk. |
| Omega-3 Supplementation Triglycerides Meta-Analysis | Conclusion In adults with HIV, omega-3 supplementation was associated with small, insignificant increases in HDL-C and meaningful reductions in triglycerides, whereas effects on other lipid fractions were inconsistent. | 1 | Bai J (2026) | Effect of omega-3 supplementation on metabolic and inflammatory markers in adults with HIV infection: a systematic review and meta-analysis. |
| Omega-3 Supplementation Triglycerides Meta-Analysis | Omega-3 supplementation was associated with a consistent reduction in CRP and modest improvements in other inflammatory biomarkers such as IL-6, while evidence for TNF- α remains inconclusive. | 1 | Bai J (2026) | Effect of omega-3 supplementation on metabolic and inflammatory markers in adults with HIV infection: a systematic review and meta-analysis. |
| Omega-3 Supplementation Triglycerides Meta-Analysis | Background People living with human immunodeficiency virus (HIV) infection frequently exhibit altered lipid profiles and persistent inflammation that contribute to long-term morbidity. | 1 | Bai J (2026) | Effect of omega-3 supplementation on metabolic and inflammatory markers in adults with HIV infection: a systematic review and meta-analysis. |
| Omega-3 Supplementation Triglycerides Meta-Analysis | Omega-3 fatty acids are commonly recommended in this population, but the magnitude and consistency of their benefits remain uncertain. | 1 | Bai J (2026) | Effect of omega-3 supplementation on metabolic and inflammatory markers in adults with HIV infection: a systematic review and meta-analysis. |
Source documents